These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21638093)

  • 1. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
    Ayez N; Lalmahomed ZS; van der Pool AE; Vergouwe Y; van Montfort K; de Jonge J; Eggermont AM; Ijzermans JN; Verhoef C
    Ann Surg Oncol; 2011 Oct; 18(10):2757-63. PubMed ID: 21638093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Wimmer K; Schwarz C; Szabo C; Bodingbauer M; Tamandl D; Mittlböck M; Kaczirek K
    Ann Surg Oncol; 2017 Jan; 24(1):236-243. PubMed ID: 27730370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.
    Allen PJ; Kemeny N; Jarnagin W; DeMatteo R; Blumgart L; Fong Y
    J Gastrointest Surg; 2003 Jan; 7(1):109-117. PubMed ID: 12559192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
    Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?
    Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M
    World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    Dupré A; Rehman A; Jones RP; Parker A; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    J Surg Oncol; 2018 May; 117(6):1330-1336. PubMed ID: 29315600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
    Arnold D; Stöltzing O; Timm S; Stein A; Geissler M; Lang H
    Z Gastroenterol; 2010 Dec; 48(12):1375-83. PubMed ID: 21125514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Zhu D; Zhong Y; Wei Y; Ye L; Lin Q; Ren L; Ye Q; Liu T; Xu J; Qin X
    PLoS One; 2014; 9(1):e86543. PubMed ID: 24466143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre study of perioperative
    Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
    BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases].
    Ivorra P; Sabater L; Calvete J; Camps B; Cervantes A; Bosch A; Plazzotta C; Cassinello N; Arlandis P; Lledó S
    Cir Esp; 2007 Sep; 82(3):166-71. PubMed ID: 17916288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases.
    Brunsell TH; Cengija V; Sveen A; Bjørnbeth BA; Røsok BI; Brudvik KW; Guren MG; Lothe RA; Abildgaard A; Nesbakken A
    Eur J Surg Oncol; 2019 Dec; 45(12):2340-2346. PubMed ID: 31350075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.